LyondellBasell's Earnings Optimism Ignores What Happened to Revenue Last Quarter

LyondellBasell Industries (NYSE: LYB) reports second-quarter 2026 earnings before the market opens on July 31, with analysts expecting a dramatic turnaround after a challenging year. The central question: can the specialty chemicals giant deliver on expectations for a 474% year-over-year earnings surge, or will operational headwinds and volatile petrochemical markets derail the recovery story that Wall Street is pricing in?

Part 1: Earnings Preview

LyondellBasell Industries is one of the world's largest plastics, chemicals, and refining companies, operating across olefins and polyolefins, intermediates and derivatives, advanced polymer solutions, refining, and technology segments. The company serves diverse end markets including packaging, automotive, construction, and consumer products.

LYB is scheduled to report Q2 2026 results before the market opens on Friday, July 31. The consensus estimate calls for $3.56 per share, with revenue expected around $9.22 billion. The company most recently reported $0.49 per share for Q1 2026, beating estimates by 58%. Compared to the year-ago quarter when LYB earned $0.62 per share, the current estimate implies +474% year-over-year growth — a remarkable expected turnaround.

Three key themes define this earnings story:

Petrochemical Margin Recovery: After enduring compressed margins throughout 2025 due to oversupply and weak demand, investors are watching for signs that the petrochemical cycle is finally turning. Improved spreads between feedstock costs and product prices would validate the aggressive earnings growth expectations and signal that the worst of the downcycle is behind the company.

Volume Growth and Demand Stabilization: With revenue missing expectations last quarter (down 6.3% year-over-year to $7.20 billion), the market needs evidence that end-market demand is stabilizing across key segments. Any commentary on order patterns, inventory levels, and customer restocking activity will be critical to assessing whether the volume recovery is sustainable.

Operational Execution Amid Volatility: LYB's recent earnings history shows wild swings — from a $0.26 loss in Q4 2025 to beats in Q1 2026 and Q3 2025, sandwiched around a significant Q2 2025 miss. Investors need confidence that management can deliver consistent execution and maintain cost discipline even as market conditions remain unpredictable.

Ahead of the release, analysts remain cautiously optimistic but divided. The consensus "Moderate Buy" rating reflects this uncertainty, with 6 Strong Buys and 2 Moderate Buys offset by 9 Holds, 1 Moderate Sell, and 2 Strong Sells. The mean price target of $66.65 suggests modest upside potential, but the wide range of estimates — from a low of $3.18 to a high of $3.91 for Q2 EPS alone — underscores the uncertainty surrounding the magnitude of the recovery.

Part 2: Historical Earnings Performance

LyondellBasell's recent earnings performance has been highly erratic, reflecting the volatile nature of petrochemical markets. Over the past four quarters, the company has alternated between beats and misses with significant magnitude swings.

The pattern shows two substantial beats: Q1 2026 delivered $0.49 versus $0.31 estimated (a +58% surprise), and Q3 2025 posted $1.01 against $0.80 expected (a +26% surprise). However, these were offset by two painful misses: Q2 2025 came in at $0.62 versus $0.87 estimated (a -29% miss), and Q4 2025 shocked with a $0.26 loss against expectations of $0.18 profit (a -244% miss).

This inconsistency suggests LYB's earnings are highly sensitive to quarterly fluctuations in feedstock costs, product pricing, and demand patterns. The company has demonstrated it can exceed expectations when conditions align, but the magnitude of the Q4 2025 miss and the Q2 2025 shortfall indicate significant execution risk. Investors should approach this release with caution, recognizing that while the most recent quarter showed strong execution, the historical pattern offers little predictability.

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

LyondellBasell typically reports earnings before the market opens, meaning Day 0 represents the first full trading session where investors react to results, while Day +1 captures follow-through momentum.

Historical price action around LYB earnings shows significant volatility, with an average absolute Day 0 move of 2.24% and an average Day 0 range of 5.63%. The Day +1 follow-through averages 1.96% with a 4.42% range, indicating that initial reactions often extend into the second session.

The most dramatic recent move came in August 2025, when the stock dropped 7.79% on earnings day with continued weakness the following session. Conversely, October 2025 saw a 2.70% Day 0 gain. The January 2026 report produced relatively muted action, while the most recent May 2026 release saw modest positive movement. This pattern suggests investors should prepare for potential swings in either direction, with the stock capable of multi-percent moves depending on whether results and guidance align with the aggressive recovery expectations embedded in current estimates.

Part 2.2: Options Market Expected Move

The options market is pricing an expected move of 7.92% (approximately $4.79) for the August expiration, significantly higher than the historical average Day 0 move of 2.24% and even exceeding the average Day 0 range of 5.63%. This elevated implied volatility suggests options traders are anticipating a larger-than-typical reaction to this earnings release, likely reflecting the uncertainty around whether LYB can deliver on the dramatic +474% year-over-year earnings growth expectations.

Part 3: What Analysts Are Saying

Wall Street maintains a "Moderate Buy" consensus on LyondellBasell, though sentiment has recently deteriorated. The average analyst recommendation stands at 3.45 (between Hold and Buy), down from 3.55 one month ago. Among the 20 analysts covering the stock, 6 rate it a Strong Buy, 2 a Moderate Buy, 9 a Hold, 1 a Moderate Sell, and 2 a Strong Sell.

The consensus price target of $66.65 implies approximately 10% upside from the current price of $60.44. However, the wide range of targets — from a low of $48.00 to a high of $88.00 — reflects significant disagreement about the company's prospects. The high estimate suggests potential upside of 46%, while the low estimate implies 21% downside risk.

The recent deterioration in sentiment, with one analyst downgrading from Strong Buy to Hold over the past month, suggests growing caution as the earnings release approaches. The concentration of Hold ratings (nearly half of all analysts) indicates many on Wall Street are taking a wait-and-see approach, wanting confirmation that the expected earnings recovery is real and sustainable before committing to more bullish stances. The presence of three sell-side ratings (including two Strong Sells) reflects skepticism that petrochemical fundamentals have truly inflected positively enough to justify current valuations.

Part 4: Technical Picture

The Barchart Technical Opinion currently shows a Sell signal at 8%, unchanged from last week but representing a significant improvement from the 24% Sell reading one month ago. This suggests the technical picture has stabilized recently after a period of weakness.

Timeframe Analysis:

• Short-term (Hold): Neutral signal indicates near-term momentum has stalled, with the stock consolidating ahead of earnings
• Medium-term (50% Sell): Moderate sell signal reflects underlying weakness in the intermediate timeframe trend
• Long-term (Hold): Neutral reading suggests the longer-term trend lacks clear direction

Trend Characteristics: The signal strength is at Minimum with direction at Weakest, indicating a fragile technical environment with limited conviction in either direction heading into the earnings release.

From a moving average perspective, LYB is trading above its 5-day ($59.62), 10-day ($60.32), 20-day ($58.21), and 200-day ($58.13) moving averages, but remains below its 50-day ($61.28) and 100-day ($67.53) averages. This mixed picture — with the stock above short-term and long-term averages but below intermediate-term levels — reflects a stock attempting to stabilize after a prolonged decline from higher levels earlier in the year. The current price of $60.44 sits in a technical no-man's land, with resistance at the 50-day average just overhead and support from the 20-day and 200-day averages below. The overall technical setup is cautionary rather than supportive, suggesting the stock needs a strong earnings beat and positive guidance to break through overhead resistance and establish a more constructive trend.